Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia

被引：0
|
作者：
Thomas Ernst
Melinda Busch
Jenny Rinke
Jana Ernst
Claudia Haferlach
James F. Beck
Andreas Hochhaus
Bernd Gruhn
机构：
[1] Universitätsklinikum Jena,Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II
[2] Universitätsklinikum Jena,Sektion für Hämatologie, Onkologie und Stammzelltransplantation, Klinik für Kinder
[3] MLL Münchner Leukämie Labor, und Jugendmedizin
来源：
Leukemia | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2046 / 2049
页数：3
相关论文
共 50 条
  • [1] Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
    Ernst, Thomas
    Busch, Melinda
    Rinke, Jenny
    Ernst, Jana
    Haferlach, Claudia
    Beck, James F.
    Hochhaus, Andreas
    Gruhn, Bernd
    LEUKEMIA, 2018, 32 (09) : 2046 - 2049
  • [2] Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
    Aram Bidikian
    Hagop Kantarjian
    Elias Jabbour
    Nicholas J. Short
    Keyur Patel
    Farhad Ravandi
    Koji Sasaki
    Ghayas C. Issa
    Blood Cancer Journal, 12
  • [3] Impact of ASXL1 Mutations on Prognosis of Chronic Phase Chronic Myeloid Leukemia
    Bidikian, Aram
    Kantarjian, Hagop
    Jabbour, Elias
    Short, Nicholas
    Ravandi, Farhad
    Issa, Ghayas
    Sasaki, Koji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S291 - S291
  • [4] Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
    Bidikian, Aram
    Kantarjian, Hagop
    Jabbour, Elias
    Short, Nicholas J.
    Patel, Keyur
    Ravandi, Farhad
    Sasaki, Koji
    Issa, Ghayas C.
    BLOOD CANCER JOURNAL, 2022, 12 (10)
  • [5] Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia
    Braun, Theodore
    Foley, Amy
    Druker, Brian J.
    Maxson, Julia E.
    BLOOD, 2018, 132
  • [6] Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations
    Oak, Jean S.
    Ohgami, Robert S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 781 - 782
  • [7] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [8] ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
    Lioba Schönfeld
    Jenny Rinke
    Anna Hinze
    Saskia N. Nagel
    Vivien Schäfer
    Thomas Schenk
    Christian Fabisch
    Tim H. Brümmendorf
    Andreas Burchert
    Philipp le Coutre
    Stefan W. Krause
    Susanne Saussele
    Fatemeh Safizadeh
    Markus Pfirrmann
    Andreas Hochhaus
    Thomas Ernst
    Leukemia, 2022, 36 : 2242 - 2249
  • [9] ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
    Schoenfeld, Lioba
    Rinke, Jenny
    Hinze, Anna
    Nagel, Saskia N.
    Schaefer, Vivien
    Schenk, Thomas
    Fabisch, Christian
    Bruemmendorf, Tim H.
    Burchert, Andreas
    le Coutre, Philipp
    Krause, Stefan W.
    Saussele, Susanne
    Safizadeh, Fatemeh
    Pfirrmann, Markus
    Hochhaus, Andreas
    Ernst, Thomas
    LEUKEMIA, 2022, 36 (09) : 2242 - 2249
  • [10] ASXL1/2 mutations and myeloid malignancies
    Edward A. Medina
    Caroline R. Delma
    Feng-Chun Yang
    Journal of Hematology & Oncology, 15
12345